|
시장보고서
상품코드
2052532
맞춤형 의료 시장 : 용도별, 적응증별, 최종 사용자별, 지역별Personalized Medicine Market, By Application, By Indication, By End User, By Geography |
||||||
맞춤형 의료 시장은 2026년에 978억 9,000만 달러에 달하고, 2033년에 1,883억 4,000만 달러에 이를 전망입니다. 2026-2033년 CAGR은 9.8%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 978억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.80% | 시장 규모 예측(2033년) : | 1,883억 4,000만 달러 |
맞춤형 의료는 각 환자의 개별적 특성에 맞추어 의료 서비스를 제공하고, 유전학, 바이오마커, 임상적 위험 요인을 바탕으로 한 표적 치료를 수행하는 것을 목표로 합니다. 이는 치료 및 질병 예방에 있어 획일적인 접근 방식에서 벗어나, 환자의 유전자, 환경, 생활 방식에 따른 개별적인 차이를 고려한 고도로 맞춤형 시스템으로의 진화를 의미합니다. 맞춤형 의료는 보다 정보에 기반한 의료적 판단을 통해 약물 부작용을 줄이고, 치료 효과를 높이며, 건강 결과를 개선할 가능성을 지니고 있습니다. 유전자 검사, 빅데이터 분석, 분자진단의 발전으로 인해 의사는 환자의 특정 질환에 대한 감수성을 유전자 수준에서 분석하고, 이에 따라 치료법을 최적화할 수 있게 됩니다. 이 신흥 분야는 개인 차원의 질병 진단, 치료 및 예방 방식을 혁신하고 있습니다.
시장 역학
맞춤형 의료 시장은 의료비 및 제약사의 의약품 개발 비용 상승, 표적 치료에 대한 수요 증가, 동반 진단(companion diagnostics)의 중요성 확대, 정밀의료에 대한 관심 고조, 연구용 유전자 데이터의 접근성 향상 등의 요인에 힘입어 성장하고 있습니다. 그러나 환자와 의사 사이에서 이 접근법에 대한 인식이 낮고, 초기 비용이 높으며, 규제상의 과제가 있어 이 시장의 성장을 저해하고 있습니다. 신흥국에서의 의료 인프라 구축은 시장에 진출하는 기업들에게 큰 성장 기회를 제공합니다. 시장을 선도하는 기업들은 빅데이터 분석에 투자하고, 진단 검사 기업들과 제휴하여 환자의 치료 성과를 높이기 위한 복합 제품을 개발하고 있습니다. 약리유전학과 동반 진단에 대한 지속적인 연구를 통해, 향후 10년 동안 맞춤형 의료의 역량은 더욱 확대될 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 맞춤형 의료 시장의 주요 기업 프로파일을 작성하고 있습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 맞춤형 의료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계의 맞춤형 의료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있습니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 맞춤형 의료 시장 : 용도별(2021-2033년)
제5장 세계의 맞춤형 의료 시장 : 적응증별(2021-2033년)
제6장 세계의 맞춤형 의료 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 맞춤형 의료 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 애널리스트의 견해
제10장 참고 문헌 및 조사 방법
KTH 26.06.17Personalized Medicine Market is estimated to be valued at USD 97.89 Bn in 2026 and is expected to reach USD 188.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 97.89 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.80% | 2033 Value Projection: | USD 188.34 Bn |
Personalized medicine aims to tailor healthcare to the individual characteristics of each patient, providing targeted treatment based on genetics, biomarkers, and clinical risk factors. It represents an evolution from a one-size-fits-all approach to treatment and disease prevention to a highly customized system that considers individual variability in patients' genes, environments, and lifestyles. Personalized medicine has the potential to reduce adverse drug reactions, enhance treatment efficacy, and improve health outcomes through better-informed medical decisions. With advancements in genetic testing, big data analytics and molecular diagnostics, it enables physicians to genetically profile patients' susceptibility to specific diseases and optimize therapies accordingly. This emerging field is transforming how diseases are diagnosed, treated, and prevented on an individual level.
Market Dynamics
The personalized medicine market is driven by factors such as rising healthcare costs and drug development costs for pharmaceutical companies, increasing demand for targeted therapies, growing prominence of companion diagnostics, rising focus on precision medicine, and availability of genetic data for research. However, lack of awareness about this approach among patients and physicians, high upfront costs, and regulatory issues hinder the growth of this market. Developing healthcare infrastructure in emerging economies provides significant growth opportunities for market players. Market leaders are investing in big data analytics and collaborating with diagnostic testing companies to develop combination products for better patient outcomes. Continued research in pharmacogenomics and companion diagnostics will further expand the capabilities of personalized medicine over the next decade.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global personalized medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Precision Biologics, Danaher Corporation, Abbott, Illumina, Inc., Exact Sciences Corporation, ASURAGEN, INC., Exagen Inc., Genentech, Inc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global personalized medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine market
Market Segmentation
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Therapeutics
- Diagnostics
- Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Immunology
- Neurology
- Cardiology
- Autoimmune Diseases
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Personalized Medicine Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Personalized Medicine Market, By Indication, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Personalized Medicine Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Personalized Medicine Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Precision Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Exact Sciences Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ASURAGEN, INC.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Exagen Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Genentech, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Berg Health
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Omada Health
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Natera
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Invitae
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Myriad Genetics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celcuity
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- InsightRX
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Axial3D
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Precision Biologics
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
